🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an Asia-Pacific regional, randomized, double-blind, multicenter tri...
Status
Completed
Location
The Affiliated Hospital of Military Medical Sciences(The 307th Hospital of Chinese PLA)
Start Date
2016-03-14
Trial ID
NCT02586025
Treatments Being Tested
This is a multicenter, open label, non-inferiority, randomized controlled c...
Status
Recruiting
Location
Sunyat-sen Memorial Hospital
Start Date
2021-12-20
Trial ID
NCT05159193
The study assesses the efficacy of neoadjuvant treatment with pyrotinib and...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2021-06-03
Trial ID
NCT04717531
Treatments Being Tested
The study is being conducted to assess the efficacy and safety of anthracyc...
Status
Unknown
Location
Breast Oncology, Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-10-08
Trial ID
NCT05871918
Treatments Being Tested
This is a global Phase III, two-arm, open-label, multicenter, randomized st...
Status
Completed
Location
Maryland Oncology Hematology
Start Date
2018-06-14
Trial ID
NCT03493854
This study was phase IB-II clinical trial that designed to evaluate the eff...
Status
Unknown
Location
Samsung Medical Center
Start Date
2019-05-27
Trial ID
NCT03881878
Treatments Being Tested
The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Status
Recruiting
Location
Skåne University Hospital
Start Date
2023-10-26
Trial ID
NCT05900206
This study is a single-arm, single-center exploratory clinical study. Twent...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-01-05
Trial ID
NCT04929548
Treatments Being Tested
The main goal of the study is to abandon breast surgery in patients with br...
Status
Recruiting
Location
Petr Krivorotko
Start Date
2019-10-08
Trial ID
NCT04293796
Treatments Being Tested
Due to the unique advantages of albumin-bound paclitaxel, several studies i...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-07-10
Trial ID
NCT05420454